Industry Trends

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.

A ScienceSoft report finds technology and demand are in place, but regulatory uncertainty looms.

HHS announces plan to create ‘most-favored-nation’ cost scale so U.S. is not subsidizing drug prices in other countries.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Trump administration tallies ‘staggering cost’ of opioid epidemic as lawmakers ponder budget.

As use of artificial intelligence grows rapidly in health care, the American Medical Association brought together an expert panel to highlight policy changes, transparency concerns and implications for physician practices.

Ultraprocessed foods, oil-based dyes are FDA targets as part of Make America Healthy Again initiative.

Public health communicator and digital strategist to lead the American Medical Association — the nation’s largest physician group.

National Comprehensive Cancer Network holds policy summit on collaboration in oncology, primary care.

Medicare data shows a shift toward larger, multispecialty and hospital-affiliated practices.

Primary care physicians are often in the best position to identify and treat patients with AUD.

‘Wild west’ of pharmaceutical sales developed as patients clamor for GLP-1s for obesity treatment.

Novavax continues working with FDA, but case could signal a shift in broader vaccine procedures.

New survey reveals a sharp increase in deferred care due to affordability concerns — even among the insured — as employers and physicians face the fallout.

What to make of the market right now? Here are insights on factors driving consolidation and strategies to build value in the physician practice management sector.

Funding freeze impacts Veterans Affairs and disrupts graduate medical education, raising concerns about future healthcare training and veteran support.

Experts warn that expanding health care conglomerates threaten competition, increase costs and limit independent practitioners' autonomy, urging regulatory action.

Teen drinking poses serious risks to adolescent health, affecting brain development and increasing addiction potential. There are effective strategies to address this issue.

Dementia costs will soar to $781 billion by 2025, driven by unpaid caregiving and lost income, highlighting the emotional toll on families.